Wolverine Trading, LLC Verona Pharma PLC Transaction History
Wolverine Trading, LLC
- $103 Billion
- Q4 2024
A detailed history of Wolverine Trading, LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Wolverine Trading, LLC holds 18,280 shares of VRNA stock, worth $1.22 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,280
Previous 20,900
12.54%
Holding current value
$1.22 Million
Previous $601,000
41.1%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding VRNA
# of Institutions
219Shares Held
70.5MCall Options Held
1.4MPut Options Held
299K-
Perceptive Advisors LLC New York, NY6.39MShares$427 Million9.9% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$373 Million18.53% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$226 Million9.42% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.13MShares$209 Million2.79% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx3.13MShares$209 Million2.81% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $4.07B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...